Herantis Pharma Oyj

HEL:HRTIS.HE

1.69 (EUR) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 00000000000000000000000000000000.0130.0130.00100.0010.00100000000
Cost of Revenue 0000000000.0800.46400.46400.46400.48400.5620000000000.0140.01400000000000000
Gross Profit 000000000-0.080-0.4640-0.4640-0.4640-0.4840-0.562000000000-0.014-0.0140.0130.0130.00100.0010.00100000000
Gross Profit Ratio 000000000000000000000000000000011111111000000
Reseach & Development Expenses 2.10.60.61.50.752.121.12.881.42.962.960.0031.51.5141.5142.31.151.7641.7640.70.70.9640.9640.550.550.8140.8140.350.350.7640.7640.60.64.9764.9762.052.051.9091.9090.50.10000
General & Administrative Expenses 000000000000000000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000000000000000000
SG&A 1.6432.4640.4421.1880.4261.4880.5431.640.7824.510.4815.2280.6423.6870.5721.3390.4463.8580.3282.4760.3740.2810.2810.3410.3410.2240.2240.2880.2880.1990.1990.2720.2720.2830.2830.3830.3830.380.380.2350.120.0270.0270.1070.077
Other Expenses 0.9875.02600.2800.1350000000000.0900.11300.1130000000001.8470002.436000001.1940.448000.3120
Operating Expenses 2.756-2.5621.0192.4080.8873.4732.4444.522.1854.512.4165.2313.9363.6872.5353.5492.0073.7452.5242.3641.4541.1871.1871.2571.2570.0820.0821.0011.0011.8470.8741.2991.2992.4361.2256.8666.8663.4013.4011.1940.4480.1280.1280.3120.184
Operating Income -2.7562.5621.281-2.408-1.204-3.473-1.812-4.52-2.185-4.59-2.295-5.695-3.936-4.151-2.029-4.013-2.007-4.229-2.115-2.926-1.463-1.178-1.178-1.257-1.257-0.971-0.971-1.001-1.001-1.847-0.937-1.273-1.273-2.436-1.218-6.865-6.865-3.007-3.007-1.194-0.448-0.128-0.128-0.312-0.184
Operating Income Ratio 0000000000000000000000000000000-100.663-100.655-3,044.595-3,044.595-11,898.244-11,877.659-7,518.308-7,518.308000000
Total Other Income Expenses Net 0.069-0.487-0.2440.6130.307-0.2-0.018-1.131-0.648-0.239-0.119-2.244-0.034-0.526-0.311-0.459-0.23-0.456-0.228-0.393-0.196-0.029-0.0290.3750.3750.9030.903-0.013-0.0130.020.024-0.026-0.026-0.024-0.0120.0730.0730.0520.052-0.796-0.008-0.005-0.005-0.01-0.009
Income Before Tax -2.6872.0751.037-1.795-0.898-3.673-1.83-5.651-2.833-4.829-2.414-7.939-3.97-4.677-2.34-4.472-2.236-4.686-2.343-3.319-1.659-1.207-1.207-0.882-0.882-0.068-0.068-1.014-1.014-1.827-0.914-1.299-1.299-2.459-1.23-6.793-6.793-2.956-2.956-1.99-0.456-0.133-0.133-0.322-0.193
Income Before Tax Ratio 0000000000000000000000000000000-102.708-102.7-3,074.355-3,074.355-11,772.267-11,751.9-7,389.03-7,389.03000000
Income Tax Expense 01.281-0.244-0.0010-0.0550-00000000-000000000000000.0250000.03000000.7960.008000.010
Net Income -2.6872.0751.037-1.795-0.898-3.673-1.83-5.651-2.833-4.829-2.414-7.939-3.97-4.677-2.34-4.472-2.236-4.686-2.343-3.319-1.659-1.207-1.207-0.882-0.882-0.068-0.068-1.014-1.014-1.852-0.914-1.299-1.299-2.49-1.23-6.793-6.793-2.956-2.956-2.785-0.463-0.133-0.133-0.331-0.193
Net Income Ratio 0000000000000000000000000000000-102.708-102.7-3,112.063-3,074.355-11,772.267-11,751.9-7,389.03-7,389.03000000
EPS -0.130.120.059-0.11-0.055-0.22-0.11-0.47-0.24-0.43-0.23-0.77-0.41-0.56-0.29-0.62-0.33-0.73-0.38-0.57-0.3-0.25-0.25-0.18-0.18-0.016-0.016-0.25-0.25-0.45-0.22-0.32-0.32-0.61-0.3-1.67-1.67-0.72-0.72-0.65-0.16-0.11-0.11-0.27-34.88
EPS Diluted -0.130.120.059-0.11-0.053-0.22-0.11-0.47-0.23-0.43-0.23-0.77-0.41-0.56-0.29-0.62-0.33-0.73-0.38-0.57-0.3-0.25-0.25-0.18-0.18-0.016-0.016-0.25-0.25-0.45-0.22-0.32-0.32-0.61-0.3-1.67-1.67-0.72-0.72-0.65-0.16-0.11-0.11-0.27-0.16
EBITDA -2.7562.562-0.244-2.4080.307-3.473-1.772-4.52-2.145-4.51-2.255-5.231-3.704-3.687-1.797-3.549-1.775-3.745-1.872-2.364-1.182-0.878-0.878-0.957-0.957-0.668-0.668-0.696-0.696-1.198-0.635-0.973-0.973-1.601-0.804-2.569-2.569-2.602-2.602-0.814-0.372-0.118-0.096-0.236-0.108
EBITDA Ratio 0000000000000000000000000000000-76.98-76.974-2,001.795-2,009.743-4,451.761-4,444.057-6,505.505-6,505.505000000